Zoetis acquires Ethos Diagnostic Science
The animal health company continues to grow its presence in the diagnostic category, which is estimated to exceed $4 billion.
Zoetis has acquired Ethos Diagnostic Science, a veterinary reference lab business unit of Ethos Veterinary Health, with a goal of enhancing its growing reference laboratory footprint. According to a company press release, the acquisition will allow Zoetis to offer comprehensive and enhanced value to veterinarians throughout the country.
“We are thrilled to add the Ethos Diagnostic Science labs to our expanding diagnostics presence in the U.S., and we look forward to working with their dedicated, trusted, board-certified pathologists and laboratory technicians,” says Lisa Lee, Zoetis senior vice president and head of global diagnostics, in the release.
Ethos Diagnostic Science currently has laboratory locations in Boston, Denver and San Diego, where clinical teams perform testing for all veterinary species in hematology, clinical chemistry, urinalysis, microbiology, parasitology, endocrinology, serology, cytology and histology.
“We’re very proud of Ethos Diagnostic Science and our lab teams who have demonstrated our core value of innovation and provided invaluable service to our clinical teams, pet families at Ethos Veterinary Health and veterinary teams of our lab customers,” says Brian Cassell, DVM, Ethos Veterinary Health’s chief strategy officer.
Zoetis expects the global veterinary diagnostics category to continue to grow faster than the animal health industry overall. According to the company, this growth is driven by pet owners’ increasing interest in rising medicalization rates, standards of veterinary care and the convenience of in-clinic testing.
“With the addition of Ethos’ labs in San Diego, Denver and Boston, we continue to build a more holistic diagnostics portfolio at Zoetis,” Lee says, “and together we can provide veterinarians with even more valuable service and accurate insights that inform the care they provide to animals.”